scholarly journals Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2

2016 ◽  
Vol 310 (3) ◽  
pp. G171-G180 ◽  
Author(s):  
Gautam Rishi ◽  
Eriza S. Secondes ◽  
Daniel F. Wallace ◽  
V. Nathan Subramaniam
Keyword(s):  
Iron Metabolism ◽  
Knockout Mice ◽  
Transferrin Receptor ◽  
Iron Homeostasis ◽  
Essential Element ◽  
Cellular Growth ◽  
Hepatic Expression ◽  
Specific Deletion ◽  
Transferrin Receptor 2

Iron is an essential element, since it is a component of many macromolecules involved in diverse physiological and cellular functions, including oxygen transport, cellular growth, and metabolism. Systemic iron homeostasis is predominantly regulated by the liver through the iron regulatory hormone hepcidin. Hepcidin expression is itself regulated by a number of proteins, including transferrin receptor 2 (TFR2). TFR2 has been shown to be expressed in the liver, bone marrow, macrophages, and peripheral blood mononuclear cells. Studies from our laboratory have shown that mice with a hepatocyte-specific deletion of Tfr2 recapitulate the hemochromatosis phenotype of the global Tfr2 knockout mice, suggesting that the hepatic expression of TFR2 is important in systemic iron homeostasis. It is unclear how TFR2 in macrophages contributes to the regulation of iron metabolism. We examined the role of TFR2 in macrophages by analysis of transgenic mice lacking Tfr2 in macrophages by crossing Tfr2 f/f mice with LysM-Cre mice. Mice were fed an iron-rich diet or injected with lipopolysaccharide to examine the role of macrophage Tfr2 in iron- or inflammation-mediated regulation of hepcidin. Body iron homeostasis was unaffected in the knockout mice, suggesting that macrophage TFR2 is not required for the regulation of systemic iron metabolism. However, peritoneal macrophages of knockout mice had significantly lower levels of ferroportin mRNA and protein, suggesting that TFR2 may be involved in regulating ferroportin levels in macrophages. These studies further elucidate the role of TFR2 in the regulation of iron homeostasis and its role in regulation of ferroportin and thus macrophage iron homeostasis.

Transferrin receptor 2 is emerging as a major player in the control of iron metabolism

2007 ◽  
Vol 2 (1) ◽  
pp. 34-55 ◽  
Author(s):  
Alessia Calzolari ◽  
Isabella Oliviero ◽  
Ugo Testa
Keyword(s):  
Iron Metabolism ◽  
Transferrin Receptor ◽  
Cellular Localization ◽  
Iron Homeostasis ◽  
Hereditary Hemochromatosis ◽  
Essential Element ◽  
Biological Properties ◽  
The Body ◽  
Major Player ◽  
Type 3

AbstractOur knowledge of mammalian iron metabolism has advanced dramatically over recent years. Iron is an essential element for virtually all living organisms. Its intestinal absorption and accurate cellular regulation is strictly required to ensure the coordinated synthesis of the numerous iron-containing proteins involved in key metabolic processes, while avoiding the uptake of excess iron that can lead to organ damage. A range of different proteins exist to ensure this fine control within the various tissues of the body. Among these proteins, transferrin receptor (TFR2) seems to play a key role in the regulation of iron homeostasis. Disabling mutations in TFR2 are responsible for type 3 hereditary hemochromatosis (Type 3 HH). This review describes the biological properties of this membrane receptor, with a particular emphasis paid to the structure, function and cellular localization. Although much information has been garnered on TFR2, further efforts are needed to elucidate its function in the context of the iron regulatory network.

scholarly journals Transferrin Receptor 2: Evidence for Ligand-induced Stabilization and Redirection to a Recycling Pathway

2007 ◽  
Vol 18 (3) ◽  
pp. 743-754 ◽  
Author(s):  
Martha B. Johnson ◽  
Juxing Chen ◽  
Nicholas Murchison ◽  
Frank A. Green ◽  
Caroline A. Enns
Keyword(s):  
Transferrin Receptor ◽  
Iron Homeostasis ◽  
Mutational Analysis ◽  
Direct Role ◽  
Recycling Endosomes ◽  
Late Endosomes ◽  
Transferrin Receptor 1 ◽  
Diferric Transferrin ◽  
Transferrin Receptor 2

Transferrin receptor 2 (TfR2) is a homologue of transferrin receptor 1 (TfR1), the protein that delivers iron to cells through receptor-mediated endocytosis of diferric transferrin (Fe2Tf). TfR2 also binds Fe2Tf, but it seems to function primarily in the regulation of systemic iron homeostasis. In contrast to TfR1, the trafficking of TfR2 within the cell has not been extensively characterized. Previously, we showed that Fe2Tf increases TfR2 stability, suggesting that trafficking of TfR2 may be regulated by interaction with its ligand. In the present study, therefore, we sought to identify the mode of TfR2 degradation, to characterize TfR2 trafficking, and to determine how Fe2Tf stabilizes TfR2. Stabilization of TfR2 by bafilomycin implies that TfR2 traffics to the lysosome for degradation. Confocal microscopy reveals that treatment of cells with Fe2Tf increases the fraction of TfR2 localizing to recycling endosomes and decreases the fraction of TfR2 localizing to late endosomes. Mutational analysis of TfR2 shows that the mutation G679A, which blocks TfR2 binding to Fe2Tf, increases the rate of receptor turnover and prevents stabilization by Fe2Tf, indicating a direct role of Fe2Tf in TfR2 stabilization. The mutation Y23A in the cytoplasmic domain of TfR2 inhibits its internalization and degradation, implicating YQRV as an endocytic motif.

scholarly journals mitoNEET Regulates Mitochondrial Iron Homeostasis Interacting with Transferrin Receptor

2018 ◽  
Author(s):  
Takaaki Furihata ◽  
Shingo Takada ◽  
Satoshi Maekawa ◽  
Wataru Mizushima ◽  
Masashi Watanabe ◽  
...  
Keyword(s):  
Knockout Mice ◽  
Transferrin Receptor ◽  
Iron Homeostasis ◽  
Mass Spectrometry Analysis ◽  
Spectrometry Analysis ◽  
Mitochondrial Ros ◽  
Mitochondrial Iron ◽  
Specific Deletion

AbstractIron is an essential trace element for regulation of redox and mitochondrial function, and then mitochondrial iron content is tightly regulated in mammals. We focused on a novel protein localized at the outer mitochondrial membrane. Immunoelectron microscopy revealed transferrin receptor (TfR) displayed an intimate relationship with the mitochondria, and mass spectrometry analysis also revealed mitoNEET interacted with TfR in vitro. Moreover, mitoNEET was endogenously coprecipitated with TfR in the heart, which indicates that mitoNEET also interacts with TfR in vivo. We generated mice with cardiac-specific deletion of mitoNEET (mitoNEET-knockout). Iron contents in isolated mitochondria were significantly increased in mitoNEET-knockout mice compared to control mice. Mitochondrial reactive oxygen species (ROS) were higher, and mitochondrial maximal capacity and reserve capacity were significantly decreased in mitoNEET-knockout mice, which was consistent with cardiac dysfunction evaluated by echocardiography. The complex formation of mitoNEET with TfR may regulate mitochondrial iron contents via an influx of iron. A disruption of mitoNEET could thus be involved in mitochondrial ROS production by iron overload in the heart.

scholarly journals Variability of the Transferrin Receptor 2 Gene in AMD

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Daniel Wysokinski ◽  
Janusz Blasiak ◽  
Mariola Dorecka ◽  
Marta Kowalska ◽  
Jacek Robaszkiewicz ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Risk Factors ◽  
Transferrin Receptor ◽  
Fenton Reaction ◽  
Iron Homeostasis ◽  
Critical Role ◽  
Age Related Macular Degeneration ◽  
Age Related ◽  
Its Gene ◽  
Transferrin Receptor 2

Oxidative stress is a major factor in the pathogenesis of age-related macular degeneration (AMD). Iron may catalyze the Fenton reaction resulting in overproduction of reactive oxygen species. Transferrin receptor 2 plays a critical role in iron homeostasis and variability in its gene may influence oxidative stress and AMD occurrence. To verify this hypothesis we assessed the association between polymorphisms of theTFR2gene and AMD. A total of 493 AMD patients and 171 matched controls were genotyped for the two polymorphisms of theTFR2gene: c.1892C>T (rs2075674) and c.−258+123T>C (rs4434553). We also assessed the modulation of some AMD risk factors by these polymorphisms. The CC and TT genotypes of the c.1892C>T were associated with AMD occurrence but the latter only in obese patients. The other polymorphism was not associated with AMD occurrence, but the CC genotype was correlated with an increasing AMD frequency in subjects withBMI<26. The TT genotype and the T allele of this polymorphism decreased AMD occurrence in subjects above 72 years, whereas the TC genotype and the C allele increased occurrence of AMD in this group. The c.1892C>T and c.−258+123T>C polymorphisms of theTRF2gene may be associated with AMD occurrence, either directly or by modulation of risk factors.

scholarly journals Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism

Nutrients ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2601
Author(s):  
Tanja Grubić Kezele ◽  
Božena Ćurko-Cofek
Keyword(s):  
Iron Metabolism ◽  
Neurological Disorders ◽  
Healthy Aging ◽  
Iron Homeostasis ◽  
Essential Element ◽  
Molecular Alterations ◽  
Age Related ◽  
Faster Development ◽  
Brain Iron Metabolism ◽  
Age Related Changes

Iron is an essential element that participates in numerous cellular processes. Any disruption of iron homeostasis leads to either iron deficiency or iron overload, which can be detrimental for humans’ health, especially in elderly. Each of these changes contributes to the faster development of many neurological disorders or stimulates progression of already present diseases. Age-related cellular and molecular alterations in iron metabolism can also lead to iron dyshomeostasis and deposition. Iron deposits can contribute to the development of inflammation, abnormal protein aggregation, and degeneration in the central nervous system (CNS), leading to the progressive decline in cognitive processes, contributing to pathophysiology of stroke and dysfunctions of body metabolism. Besides, since iron plays an important role in both neuroprotection and neurodegeneration, dietary iron homeostasis should be considered with caution. Recently, there has been increased interest in sex-related differences in iron metabolism and iron homeostasis. These differences have not yet been fully elucidated. In this review we will discuss the latest discoveries in iron metabolism, age-related changes, along with the sex differences in iron content in serum and brain, within the healthy aging population and in neurological disorders such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and stroke.

scholarly journals Role of iron metabolism-regulator hepcidin in perinatal iron homeostasis

2010 ◽  
Vol 151 (3) ◽  
pp. 83-91 ◽  
Author(s):  
Ádám Balogh ◽  
Szilvia Bősze ◽  
Kata Horváti ◽  
Gábor Mező ◽  
Sándor Kéki ◽  
...  
Keyword(s):  
Iron Metabolism ◽  
Iron Homeostasis

A hepcidin egy nemrégiben felfedezett, defenzin típusú peptid, amely központi szerepet játszik a vasháztartás szabályozásában. A hepcidin csökkenti a vastranszportban szerepet játszó molekulák expresszióját, így gátolja a vas gastrointestinalis rendszerből való felszívódását, makrofágokból való felszabadulását, csökkentve ezzel a szérum vasszintjét. A hepcidin vasháztartásban betöltött szerepének tisztázása segíthet a gyulladásos és krónikus betegségekben bekövetkező anémia pontosabb megértésében. Munkánk kezdetén a hepcidin kimutatására alkalmas, kereskedelmi forgalomban elérhető módszer nem állt rendelkezésre. Célunk volt egy, a vizelethepcidin kimutatására alkalmas módszer kidolgozása, valamint hogy ezen módszer segítségével vizsgáljuk a hepcidin jelentőségét a perinatalis vasháztartásban. Munkánk során a natív, emberi hepcidin aminosav-szekvenciájának megfelelően állítottunk elő peptidszármazékokat, amelyek közül az 1-7 peptidszármazékról igazoltuk, hogy alkalmas lehet a natív hepcidin standard helyettesítésére immunreakción alapuló módszerek fejlesztésekor. Kidolgoztunk egy, az emberi vizelethepcidin mennyiségi meghatározására alkalmas, lézerdeszorpciós tömegspektrometriás, szemikvantitatív módszert, amelyben az általunk szintetizált acetil-1-25 peptidszármazékot mint hepcidinszerű belső standardot elsőként alkalmaztuk. Kidolgoztunk a vizelet tisztítására és a vizelethepcidin koncentrálására alkalmas, szilárd fázisú extrakción alapuló módszert. Az általunk kidolgozott módszerrel elsőként mértük egészséges újszülöttek vizelethepcidin-szintjét, valamint egy kereskedelmi forgalomban elérhető módszerrel a szérumprohepcidin-szintjét. Kimutattuk, hogy az érett újszülöttek korai adaptációja során a szérumprohepcidin-szint nem változik, a vizelethepcidin viszont szignifikánsan nő. A szérumprohepcidin- és a vizelethepcidin-szintek egymással nem mutattak összefüggést. Kimutattuk, hogy az érett újszülöttek vasháztartásának korai adaptációja során a szérumprohepcidin-szintek kizárólag a vörösvérsejtek átlagos hemoglobinkoncentrációjával, míg a vizelethepcidin-szintek a szérumvasszinttel és teljes vaskötő kapacitással mutattak összefüggést. Kimutattuk, hogy az érett újszülöttek vasháztartásának korai adaptációja során a köldökzsinórvér-mintákban az alacsonyabb szérumprohepcidin-szintek esetén szabad vas jelenléte igazolható. Összefoglalva: Eredményeink alapján elmondhatjuk, hogy a hepcidinnek valószínűleg szerepe van az újszülöttek korai, a vasháztartást érintő adaptációjában, azonban további vizsgálatok szükségesek ahhoz, hogy ezt az összefüggést biztosan megállapíthassuk.

scholarly journals Essential Role of Ferritin Pfr in Helicobacter pylori Iron Metabolism and Gastric Colonization

2002 ◽  
Vol 70 (7) ◽  
pp. 3923-3929 ◽  
Author(s):  
Barbara Waidner ◽  
Stefan Greiner ◽  
Stefan Odenbreit ◽  
Holger Kavermann ◽  
Jyoti Velayudhan ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Iron Metabolism ◽  
Essential Element ◽  
Iron Starvation ◽  
Iron Storage ◽  
Gastric Colonization ◽  
H Pylori ◽  
Iron Pool

ABSTRACT The reactivity of the essential element iron necessitates a concerted expression of ferritins, which mediate iron storage in a nonreactive state. Here we have further established the role of the Helicobacter pylori ferritin Pfr in iron metabolism and gastric colonization. Iron stored in Pfr enabled H. pylori to multiply under severe iron starvation and protected the bacteria from acid-amplified iron toxicity, as inactivation of the pfr gene restricted growth of H. pylori under these conditions. The lowered total iron content in the pfr mutant, which is probably caused by decreased iron uptake rates, was also reflected by an increased resistance to superoxide stress. Iron induction of Pfr synthesis was clearly diminished in an H. pylori feoB mutant, which lacked high-affinity ferrous iron transport, confirming that Pfr expression is mediated by changes in the cytoplasmic iron pool and not by extracellular iron. This is well in agreement with the recent discovery that iron induces Pfr synthesis by abolishing Fur-mediated repression of pfr transcription, which was further confirmed here by the observation that iron inhibited the in vitro binding of recombinant H. pylori Fur to the pfr promoter region. The functions of H. pylori Pfr in iron metabolism are essential for survival in the gastric mucosa, as the pfr mutant was unable to colonize in a Mongolian gerbil-based animal model. In summary, the pfr phenotypes observed give new insights into prokaryotic ferritin functions and indicate that iron storage and homeostasis are of extraordinary importance for H. pylori to survive in its hostile natural environment.

scholarly journals Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease

2020 ◽  
Author(s):  
Chiara Milanese ◽  
Sylvia Gabriels ◽  
Sander Barnhoorn ◽  
Silvia Cerri ◽  
Ayse Ulusoy ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Substantia Nigra ◽  
Iron Overload ◽  
Transferrin Receptor ◽  
Dopaminergic Neurons ◽  
Iron Homeostasis ◽  
Alpha Synuclein ◽  
Substantia Nigra Pars Compacta ◽  
Transferrin Receptor 2

AbstractAlterations in the metabolism of iron and its accumulation in the substantia nigra pars compacta accompany the pathogenesis of Parkinson’s disease (PD). Changes in iron homeostasis also occur during aging, which constitutes a PD major risk factor. As such, mitigation of iron overload via chelation strategies has been considered a plausible disease modifying approach. Iron chelation, however, is imperfect because of general undesired side effects and lack of specificity; more effective approaches would rely on targeting distinctive pathways responsible for iron overload in brain regions relevant to PD and, in particular, the substantia nigra. We have previously demonstrated that the Transferrin/Transferrin Receptor 2 (TfR2) iron import mechanism functions in nigral dopaminergic neurons, is perturbed in PD models and patients, and therefore constitutes a potential therapeutic target to halt iron accumulation. To validate this hypothesis, we generated mice with targeted deletion of TfR2 in dopaminergic neurons. In these animals, we modeled PD with multiple approaches, based either on neurotoxin exposure or alpha-synuclein proteotoxic mechanisms. We found that TfR2 deletion can provide neuroprotection against dopaminergic degeneration, and against PD- and aging-related iron overload. The effects, however, were significantly more pronounced in females rather than in males. Our data indicate that the TfR2 iron import pathway represents an amenable strategy to hamper PD progression. Data also suggest, however, that therapeutic strategies targeting TfR2 should consider a potential sexual dimorphism in neuroprotective response.

Sign in / Sign up

Export Citation Format

Share Document